GlassScriptPhysician profile
Fenglaly C Lee
NPI 1730239682
$639.31
in general payments reported to CMS, 2019-2025
9 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.53 · 2020: $52.58 · 2021: $41.56 · 2022: $15.37 · 2023: $59.43 · 2024: $261 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $250.00 | 2024 | Daxxify |
| Hologic Sales and Service, LLC | $152.37 | 2022-2025 | Myosure Tissue Removal Device, Acessa Provu System, Aptima |
| Abbvie INC. | $54.06 | 2021-2023 | |
| Dysis Medical, INC. | $52.58 | 2020 | |
| Optumhealth Care Solutions, LLC | $46.51 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Mayne Pharma Commercial LLC | $31.82 | 2024-2025 | |
| Merz North America, INC. | $22.94 | 2025 | |
| Therapeuticsmd, INC. | $17.50 | 2021 | |
| Smith+Nephew, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fenglaly Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.